{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:34:44Z","timestamp":1792017284142,"version":"4.4.0"},"reference-count":41,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi231216-4\"><jats:title>Importance<\/jats:title><jats:p>Solid organ transplant recipients are at high risk of severe infection with SARS-CoV-2 compared with the general population. However, factors associated with COVID-19\u2013related severity in this population are still insufficiently explored in the literature.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231216-5\"><jats:title>Objective<\/jats:title><jats:p>To examine which health conditions and immunosuppressive drugs for preventing graft rejection are associated with the risk of COVID-19\u2013related hospitalization in solid organ transplant recipients.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231216-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>Using the French National Health Data System, this cohort study assessed patients of any age who received transplants between their date of birth and entry into the cohort on February 15, 2020. The cohort was followed up between February 15, 2020, and July 31, 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231216-7\"><jats:title>Exposures<\/jats:title><jats:p>Immunosuppressive drugs, including steroids, and health conditions (age, sex, and comorbidities).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231216-8\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>The main outcome was hospitalization for COVID-19, defined by main diagnostic <jats:italic>International Statistical Classification of Diseases and Related Health Problems, Tenth Revision<\/jats:italic> (<jats:italic>ICD-10<\/jats:italic>) codes. Factors associated with the outcome were identified with a nonconditional logistic regression. Confounding by indication was controlled using a multivariable model with adjustment for individual confounders. Each transplanted organ was examined separately.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231216-9\"><jats:title>Results<\/jats:title><jats:p>Overall, 60\u202f456 participants (median [IQR] age, 59 [47-67] years; 63.7% male) were included in the study, of whom 41\u202f463 (68.6%) had kidney transplants, 14\u202f464 (23.9%) had liver transplants, 5327 (8.8%) had heart transplants, and 2823 (4.6%) had lung transplants. Among them, 12.7% of kidney transplant recipients, 6.4% of liver transplant recipients, 12.9% of heart transplant recipients, and 18.0% of lung transplant recipients were hospitalized for COVID-19. In kidney transplant recipients, steroids (adjusted odds ratio [AOR], 1.60; 95% CI, 1.49-1.73) and mycophenolic acid (AOR, 1.37; 95% CI, 1.25-1.51) were associated with a high risk of hospitalization. In liver transplant recipients, tacrolimus (AOR, 0.77; 95% CI, 0.61-0.98) was associated with a decreased risk, and steroids (AOR, 1.60; 95% CI, 1.38-1.86) and mycophenolic acid (AOR, 1.61; 95% CI, 1.37-1.90) were associated with an increased risk of hospitalizations. In heart transplant recipients, cyclosporine (AOR, 0.67; 95% CI, 0.47-0.94) was associated with a decreased risk, and steroids (AOR, 1.42; 95% CI, 1.11-1.82), mycophenolic acid (AOR, 1.29; 95% CI, 1.02-1.64), sirolimus (AOR, 2.71; 95% CI, 1.20-6.09), and everolimus (AOR, 1.24; 95% CI, 1.01-1.51) were associated with an increased risk of hospitalization. Only steroids (AOR, 1.72; 95% CI, 1.19-2.48) were associated with a high risk of COVID-19 hospitalization in lung transplant recipients.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi231216-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This study suggests that mycophenolic acid, sirolimus, and steroids are associated with an increased risk of COVID-19\u2013related hospitalization in solid organ transplant recipients. These results should be considered by clinicians treating transplant recipients and may help inform epidemic-related decisions for this population in the future.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.42006","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T16:33:28Z","timestamp":1699374808000},"page":"e2342006","source":"Crossref","is-referenced-by-count":45,"title":["COVID-19 Hospitalization in Solid Organ Transplant Recipients on Immunosuppressive Therapy"],"prefix":"10.1001","volume":"6","author":[{"given":"Epiphane","family":"Kolla","sequence":"first","affiliation":[{"name":"EPI-PHARE, Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France"},{"name":"Anti-Infective Evasion and Pharmacoepidemiology Team, INSERM UMR1018, School of Medicine Simone Veil, University Versailles Saint-Quentin-en-Yvelines, Paris-Saclay University, Montigny-Le-Bretonneux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Weill","sequence":"additional","affiliation":[{"name":"EPI-PHARE, Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Zaidan","sequence":"additional","affiliation":[{"name":"Department of Nephrology-Dialysis-Transplantation, Bic\u00eatre University Hospital, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris-Saclay University, Le Kremlin-Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"De Martin","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris, Hepato-Biliary Centre, Paul Brousse Hospital, Unit INSERM 1193, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Colin De Verdiere","sequence":"additional","affiliation":[{"name":"Departement of Lung Transplantation and Mucoviscidose Reference Centre, Foch Hospital, Suresnes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Semenzato","sequence":"additional","affiliation":[{"name":"EPI-PHARE, Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Zureik","sequence":"additional","affiliation":[{"name":"EPI-PHARE, Scientific Interest Group in Epidemiology of Health Products, French National Agency for the Safety of Medicines and Health Products, French National Health Insurance, Saint-Denis, France"},{"name":"Anti-Infective Evasion and Pharmacoepidemiology Team, INSERM UMR1018, School of Medicine Simone Veil, University Versailles Saint-Quentin-en-Yvelines, Paris-Saclay University, Montigny-Le-Bretonneux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lamiae","family":"Grimaldi","sequence":"additional","affiliation":[{"name":"Anti-Infective Evasion and Pharmacoepidemiology Team, INSERM UMR1018, School of Medicine Simone Veil, University Versailles Saint-Quentin-en-Yvelines, Paris-Saclay University, Montigny-Le-Bretonneux, France"},{"name":"Clinical Research Unit, Universit\u00e9 Paris-Saclay, Direction of Clinical Research, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"zoi231216r1"},{"key":"zoi231216r2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100158","article-title":"Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people.","volume":"8","author":"Semenzato","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"zoi231216r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100441","article-title":"Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: a cohort study of 28 million people in France.","volume":"19","author":"Semenzato","year":"2022","journal-title":"Lancet Reg Health Eur"},{"issue":"5","key":"zoi231216r4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-044684","article-title":"Risk factors for severity of COVID-19: a rapid review to inform vaccine prioritisation in Canada.","volume":"11","author":"Wingert","year":"2021","journal-title":"BMJ Open"},{"issue":"2","key":"zoi231216r5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1615\/CritRevEukaryotGeneExpr.v25.i2","article-title":"Current state of immunosuppression: past, present, and future.","volume":"25","author":"Karam","year":"2015","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1","key":"zoi231216r6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/TP.0000000000003523","article-title":"COVID-19 and solid organ transplantation: a review article.","volume":"105","author":"Azzi","year":"2021","journal-title":"Transplantation"},{"issue":"4","key":"zoi231216r7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.nephro.2021.01.002","article-title":"Covid-19 en transplantation r\u00e9nale, le\u00e7ons du registre fran\u00e7ais.","volume":"17","author":"Caillard","year":"2021","journal-title":"Nephrol Ther"},{"issue":"4","key":"zoi231216r8","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.v35.4","article-title":"Outcomes of COVID-19 in hospitalized solid organ transplant recipients compared to a matched cohort of non-transplant patients at a national healthcare system in the United States.","volume":"35","author":"Fisher","year":"2021","journal-title":"Clin Transplant"},{"issue":"11","key":"zoi231216r9","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1111\/ajt.17142","article-title":"Outcomes following SARS-CoV-2 infection in individuals with and without solid organ transplantation\u2014a Danish nationwide cohort study.","volume":"22","author":"Overvad","year":"2022","journal-title":"Am J Transplant"},{"issue":"6","key":"zoi231216r10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1097\/TP.0000000000003670","article-title":"Outcomes of COVID-19 in solid organ transplant recipients: a propensity-matched analysis of a large research network.","volume":"105","author":"Hadi","year":"2021","journal-title":"Transplantation"},{"issue":"8","key":"zoi231216r11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/pds.v26.8","article-title":"The national healthcare system claims databases in France, SNIIRAM and EGB: powerful tools for pharmacoepidemiology.","volume":"26","author":"Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"zoi231216r12","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.7326\/M22-0988","article-title":"Risk for myocardial infarction, stroke, and pulmonary embolism following COVID-19 vaccines in adults younger than 75 years in France.","volume":"175","author":"Botton","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi231216r13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2021-000104","article-title":"Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study.","volume":"1","author":"Bouillon","year":"2022","journal-title":"BMJ Med"},{"key":"zoi231216r14","doi-asserted-by":"publisher","first-page":"i2002","DOI":"10.1136\/bmj.i2002","article-title":"Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study.","volume":"353","author":"Weill","year":"2016","journal-title":"BMJ"},{"issue":"3","key":"zoi231216r15","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/AOG.0000000000004281","article-title":"Effects of the coronavirus disease 2019 (COVID-19) lockdown on the use of contraceptives and ovulation inductors in France.","volume":"137","author":"Roland","year":"2021","journal-title":"Obstet Gynecol"},{"issue":"2","key":"zoi231216r16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.7326\/M18-1512","article-title":"Effectiveness and safety of reference infliximab and biosimilar in Crohn disease: a French equivalence study.","volume":"170","author":"Meyer","year":"2019","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi231216r17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2458-9-33","article-title":"Ecological association between a deprivation index and mortality in France over the period 1997-2001: variations with spatial scale, degree of urbanicity, age, gender and cause of death.","volume":"9","author":"Rey","year":"2009","journal-title":"BMC Public Health"},{"key":"zoi231216r18","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d\u2019information interr\u00e9gimes de l\u2019Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France.","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"issue":"9","key":"zoi231216r19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/MLR.0000000000001745","article-title":"The economic burden of disease in France from the national health insurance perspective: the healthcare expenditures and conditions mapping used to prepare the French Social Security Funding Act and the Public Health Act.","volume":"60","author":"Rachas","year":"2022","journal-title":"Med Care"},{"issue":"12","key":"zoi231216r20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023357","article-title":"Association of statins for primary prevention of cardiovascular diseases with hospitalization for COVID-19: a nationwide matched population-based cohort study.","volume":"11","author":"Bouillon","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"2-3","key":"zoi231216r21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action.","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"issue":"6","key":"zoi231216r22","first-page":"281","article-title":"Immunosuppressive drugs after solid organ transplantation.","volume":"71","author":"van Sandwijk","year":"2013","journal-title":"Neth J Med"},{"issue":"11","key":"zoi231216r23","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia.","volume":"221","author":"Wang","year":"2020","journal-title":"J Infect Dis"},{"issue":"1","key":"zoi231216r24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2020.07.040","article-title":"Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients.","volume":"74","author":"Colmenero","year":"2021","journal-title":"J Hepatol"},{"key":"zoi231216r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104392","article-title":"Predictive factors for disease progression in hospitalized patients with coronavirus disease 2019 in Wuhan, China.","volume":"127","author":"Zhang","year":"2020","journal-title":"J Clin Virol"},{"issue":"11","key":"zoi231216r26","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1111\/j.1600-6143.2011.03674.x","article-title":"Cytomegalovirus incidence between everolimus versus mycophenolate in de novo renal transplants: pooled analysis of three clinical trials.","volume":"11","author":"Brennan","year":"2011","journal-title":"Am J Transplant"},{"issue":"8","key":"zoi231216r28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.gastrohep.2020.06.003","article-title":"Liver transplant immunosuppression during the covid-19 pandemic.","volume":"43","author":"Forns","year":"2020","journal-title":"Gastroenterol Hepatol"},{"key":"zoi231216r29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijid.2021.12.327","article-title":"Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry.","volume":"116","author":"Calder\u00f3n-Parra","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"4","key":"zoi231216r30","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1111\/bcp.v87.4","article-title":"Hospitalization for COVID-19 in patients treated with selected immunosuppressant and immunomodulating agents, compared to the general population: a Danish cohort study.","volume":"87","author":"N\u00f8rg\u00e5rd","year":"2021","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"zoi231216r31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002024","article-title":"Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study.","volume":"13","author":"Fardet","year":"2016","journal-title":"PLoS Med"},{"issue":"6","key":"zoi231216r32","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1681\/ASN.2020030348","article-title":"COVID-19 and calcineurin inhibitors: should they get left out in the storm?","volume":"31","author":"Willicombe","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"zoi231216r33","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1053\/j.gastro.2020.11.045","article-title":"Protective role of tacrolimus, deleterious role of age and comorbidities in liver transplant recipients with Covid-19: results from the ELITA\/ELTR Multi-center European Study.","volume":"160","author":"Belli","year":"2021","journal-title":"Gastroenterology"},{"issue":"4","key":"zoi231216r34","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.gastro.2020.12.050","article-title":"Tacrolimus: unlikely harmful and perhaps helpful in liver transplant recipients with COVID-19.","volume":"160","author":"Pearson","year":"2021","journal-title":"Gastroenterology"},{"issue":"7","key":"zoi231216r35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0254822","article-title":"High mortality among kidney transplant recipients diagnosed with coronavirus disease 2019: results from the Brazilian multicenter cohort study.","volume":"16","author":"Requi\u00e3o-Moura","year":"2021","journal-title":"PLoS One"},{"key":"zoi231216r37","first-page":"77","article-title":"The French organ transplant data system.","volume":"116","author":"Strang","year":"2005","journal-title":"Stud Health Technol Inform"},{"issue":"7","key":"zoi231216r38","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.nephro.2018.03.004","article-title":"Description des traitements immunosuppresseurs d\u2019entretien post-greffe r\u00e9nale \u00e0 travers le syst\u00e8me national de l\u2019Assurance maladie.","volume":"14","author":"Sitruk","year":"2018","journal-title":"Nephrol Ther"},{"issue":"12","key":"zoi231216r39","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3390\/biology10121349","article-title":"COVID-19 in solid organ transplant recipient: exploring cumulative incidence, seroprevalence and risk factors for disease severity.","volume":"10","author":"Caldara","year":"2021","journal-title":"Biology (Basel)"},{"issue":"8","key":"zoi231216r40","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1111\/ajt.16596","article-title":"COVID-19 in solid organ transplant recipients: a national cohort study from Sweden.","volume":"21","author":"S\u00f8fteland","year":"2021","journal-title":"Am J Transplant"},{"issue":"11","key":"zoi231216r41","doi-asserted-by":"publisher","first-page":"e4090","DOI":"10.1093\/cid\/ciaa1097","article-title":"Coronavirus disease 2019 in solid organ transplant: a multicenter cohort study.","volume":"73","author":"Kates","year":"2021","journal-title":"Clin Infect Dis"},{"key":"zoi231216r27","unstructured":"Ader? PF, Anglicheau? PD, Bertrand? DD, . Prise en charge de l\u2019infection due au SARS-CoV-2 chez les patients adultes transplant\u00e9s d\u2019organe solide [Internet]. April 2020. Accessed October 3, 2023. https:\/\/www.transplantation-francophone.org\/images\/public\/COVID19_et_transplantees_d_organes_solides_Guide_pratiquev1_SFT_SFNDT_SP.pdf"},{"key":"zoi231216r36","unstructured":"Agence de la Biom\u00e9decine. Rapport m\u00e9dical et scientifique. March 2, 2023. Accessed October 3, 2023. https:\/\/rams.agence-biomedecine.fr\/archives-1"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2811462\/kolla_2023_oi_231216_1698415363.40702.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T16:33:33Z","timestamp":1699374813000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2811462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.42006","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}